2.1 Study design In this prospective, double-blind, cross-over interventional study, patients were randomized in balanced blocks (1:1) into two groups: Sequence 1, HA-first, received the control product (containing only hyaluronic acid 0.2%) for 4 weeks, followed by a 1-week washout, and then the experimental product (hyaluronic acid 0.2% + butyroyl glutathione 0.4%) for 4 weeks
doi: 10.3389/fncel.2024.1405782 Received 23 March 2024 Accepted 26 July 2024 Published 07 August 2024 Volume 18 - 2024 Edited by Abdullah Shaito, Qatar University, Qatar Reviewed by Michael John Hylin, Southern Illinois University Carbondale, United States Yuxiang Fei, China Pharmaceutical University, China Alexander V
However, there was a significant 40 and 34% decrease in ovarian cancer incidence for the highest versus lowest quintile for kaempferol and luteolin intake, respectively [158]
Maintain a stable weight and follow your surgeon's scar management advice to preserve the long-term result.